TriSalus Life Sciences, Inc. (TLSI)
3.41
+0.14
(+4.28%)
USD |
NASDAQ |
May 29, 16:00
3.41
0.00 (0.00%)
Pre-Market: 20:00
TriSalus Life Sciences Total Assets (Quarterly) : 70.98M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Anika Therapeutics, Inc. | 179.39M |
| Savara, Inc. | 221.64M |
| Vericel Corp. | 485.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.17M |
| Shareholders Equity (Quarterly) | 12.81M |
| Debt to Equity Ratio | 2.693 |
| Current Ratio | 5.781 |
| Net Debt Paydown Yield | -0.88% |